A DNA vaccine encoding mutated HPV58 mE6E7-Fc-GPI fusion antigen and GM-CSF and B7.1

References

• ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002CA Cancer J Clin2005557410815761078
   PubMed Web of Science ®Google Scholar
• WalboomersJMJacobsMVManosMMHuman papillomavirus is a necessary cause of invasive cervical cancer worldwideJ Pathol1999189121910451482
   PubMed Web of Science ®Google Scholar
• VillaLLCostaRLPettaCAProphylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLancet Oncol2005627127815863374
   PubMed Web of Science ®Google Scholar
• HarperDMFrancoELWheelerCGlaxoSmithKline HPV Vaccine Study Group. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialLancet20043641757176515541448
   PubMed Web of Science ®Google Scholar
• SchillerJTCastellsaguéXVillaLLHildesheimAAn update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial resultsVaccine2008265361
   PubMed Web of Science ®Google Scholar
• CliffordGMSmithJSPlummerMMuñozNFranceschiSHuman papillomavirus types in invasive cervical cancer worldwide: a meta analysisBr J Cancer200388637312556961
   PubMed Web of Science ®Google Scholar
• PengSTrimbleCHeLCharacterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic miceGene Ther200613677716107858
   PubMed Web of Science ®Google Scholar
• PengSJiHTrimbleCDevelopment of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6J Virol2004788468847615280455
   PubMed Web of Science ®Google Scholar
• RessingMESetteABrandtRMHuman CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptidesJ Immunol1995154593459437538538
   PubMed Web of Science ®Google Scholar
• BaoYPLiNSmithJSQiaoYLACCPAB membersHuman papillomavirus type distribution in women from Asia: a meta-analysisInt J Gynecol Cancer200818717917466054
   PubMed Web of Science ®Google Scholar
• GaoQSinghLKumarASrinivasanSWazerDEBandVHuman papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cellsJ Virol2001754459446611287601
   PubMed Web of Science ®Google Scholar
• MungerKBasileJRDuensingSBiological activities and molecular targets of the human papillomavirus E7 oncoproteinOncogene2001207888789811753671
   PubMed Web of Science ®Google Scholar
• MungerKBaldwinAEdwardsKMMechanisms of human papillomavirus-induced oncogenesisJ Virol200478114511146015479788
   PubMed Web of Science ®Google Scholar
• NguyenDXWestbrookTFMcCanceDJHuman papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrestJ Virol200276619632 doi: 0.1128/JVI.76.2.619-632.200211752153
   PubMed Web of Science ®Google Scholar
• SomasundaramCTakarnatsuHAndreoniCEnhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky’s disease virusVet Immunol Immunopathol1999703–427728710507367
   PubMed Web of Science ®Google Scholar
• Ou-YangPHwangLHTacMHCo-delivery of GM-CSF gene enhances the immune responses of hepatitis C viral core protein-expressing DNA vaccine: role of dendritic cellsJ Med Virol200266332032811793383
   PubMed Web of Science ®Google Scholar
• KimJJNottinghamLKWilsonDMEngineering DNA vaccines via co-delivery of co-stimulatory molecule genesVaccine19981619182818359795388
   PubMed Web of Science ®Google Scholar
• ZhengGXLiuSRWangPJArming tumor-reactive T cells with costimulator B7.1 enhances therapeutic efficacy of the T cellsCancer Res200666136793679916818656
   PubMed Web of Science ®Google Scholar
• ZhouXQianXZhaoQLuYXiongMEfficient expression of modified human papillomavirus 16 E6/E7 fusion protein and the antitumor efficacy in a mouse modelBiol Pharm Bull20042730330714993792
   PubMed Web of Science ®Google Scholar
• CassettiMCMcElhineySPShahabiVAntitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genesVaccine20042252052714670335
   PubMed Web of Science ®Google Scholar
• LuoLQLiJZhangYHTransforming activity and immunogenicity of HPV58 E7International Symposium on Biology of Cancer Prevention and Treatment, Beijing, 1999BeijingChinese Society of Oncology, Chinese Medical Association
   Google Scholar
• McIntyreMCFrattiniMGGrossmanSRLaiminsLAHPV 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb bindingJ Virol199367631428497045
   PubMed Web of Science ®Google Scholar
• OosterhuisKOhlschlägerPvan den BergJHPreclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7Int J Cancer201112939740621207427
   PubMed Web of Science ®Google Scholar
• ZhaoKJChengHZhuKJRecombined DNA vaccines encoding calreticulin linked to HPV6bE7 enhance immune response and inhibit angiogenic activity in B16 melanoma mouse model expressing HPV 6bE7 antigenArch Dermatol Res2006298647216710741
   PubMed Web of Science ®Google Scholar
• SmithJSLindsayLHootsBHuman papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis updateInt J Cancer200712162163217405118
   PubMed Web of Science ®Google Scholar
• KaranamBGambhiraRPengSVaccination with HPV16-L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunityVaccine2009271040104919095032
   PubMed Web of Science ®Google Scholar
• ZhaoLLiuBRenJImmunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18Virol J2011830231221672263
   PubMed Web of Science ®Google Scholar
• WiekingBGVermeerDWSpanosWCA non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumorsCancer Gene Ther20121966767422918471
   PubMed Web of Science ®Google Scholar
• LuoLQLiJZhangYHZhangYHExperimental study of the immuno-protective activity of recombinant vaccinia virus expressing HPV58 E7Zhongguo Yi Xue Ke Xue Yuan Xue Bao200325434612905606
   PubMedGoogle Scholar
• DengDLiaoSBaiXThe preparation of human papillomavirus type 58 vaccine and exploring its biological activity and immunogenicity in vitroInt J Gynecol Cancer20112198899521738041
   PubMed Web of Science ®Google Scholar
• HungCFMonieAAlvarezRDWuTCDNA vaccines for cervical cancer: from bench to bedsideExp Mol Med20073967968918160838
   PubMed Web of Science ®Google Scholar
• FerroneCRPeralesMAGoldbergSMAdjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domainsClin Cancer Res2006125511551917000687
   PubMed Web of Science ®Google Scholar
• IkezawaHGlycosylphosphatidylinositol (GPI)-anchored proteinsBiol Pharm Bull20022540941711995915
   PubMed Web of Science ®Google Scholar
• RafiqKBergtoldAClynesRImmune complex-mediated antigen presentation induces tumor immunityJ Clin Invest2002110717912093890
   PubMed Web of Science ®Google Scholar
• LiuRZhouCWangDEnhancement of DNA vaccine potency by sandwiching antigen-coding gene between secondary lymphoid tissue chemokine (SLC) and IgG Fc fragment genesCancer Biol Ther2006542743416575207
   PubMed Web of Science ®Google Scholar
• MaCHZhangYWangXYHuman endostain gene transfer. Either naked or with liposome, has the same inhibitory effect on growth of mouse liver tumor cells in vivoWorld J Gastroenterol200410192874287715334690
   PubMed Web of Science ®Google Scholar
• LiJWGongJYLiKConstruction of a fusion expression plasmid containing the G250 gene and human granulocyte-macrophage colony stimulating factor and its significance in renal cell carcinomaOncol Lett20112234334722866087
   PubMed Web of Science ®Google Scholar
• LiuNYanJRanDLCloning and expression of fusion gene of human GM-CSF and B7.1 in bicistronic eukaryotic vector pVAX1-IRESBull Acad Mil Med Sci200832249252
   Google Scholar
• Allera-MoreauCChomaratPAudinotVThe use of IRES-based bicistronic vectors allows the stable expression of recombinant G-protein coupled receptors such as NPY5 and histamine 4Biochimie20068873774616808994
   PubMed Web of Science ®Google Scholar
• PanPYLiYLiQIn situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene deliveryCancer Immunol Immunother200453172512955480
   PubMed Web of Science ®Google Scholar
• MellmanISteinmanRMDendritic cells: specialized and regulated antigen processing machinesCell200110625525811509172
   PubMed Web of Science ®Google Scholar
• RenSPWuCTHuangWRAdenoviral-mediated transfer of human wild-type p53, GM-CSF and B7.1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitroCancer Immunol Immunother20065537538516001164
   PubMed Web of Science ®Google Scholar
• ScherpenisseMScheppRMMollersMMeijerCJBerbersGAvan der KlisFRCharacteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclassesPLoS One201389797
   Web of Science ®Google Scholar
• DraperEBissettSLHowell-JonesRA randomized, observer-blinded immunogenicity trial of Cervarix and Gardasil human papillomavirus vaccines in 12–15 year old girlsPLoS One201389861825
   Google Scholar